Oncology CoPilot

10/01/2026

When you or someone you love is facing cancer, understanding the treatment options can make a meaningful difference.

We created the Oncology CoPilot Patient Guide to explain how we use advanced molecular testing, AI-guided treatment intelligence, and functional testing to help identify and prioritize treatment options for an individual patient.

Our work is especially focused on patients with rare pediatric and pancreatic cancers, where treatment choices can be limited and every option matters.

We’re working to make this approach accessible to more patients and families.

💙 If you’re a patient, caregiver, or advocate, take a look at our Patient Guide and reach out if you’d like to learn more.

09/22/2026

We’re looking forward to connecting with the pancreatic cancer community at the PanCAN Summit in San Diego!

Our featured research explores how shared transcriptomic patterns across cancer types could help inform personalized treatment response assessment in advanced pancreatic cancer.

Join us September 24, 6:30–8:30 PM, at the Bivouac Ballroom, lower level of the US Grant Hotel. We hope to see you there!

09/14/2026

RASONQUE Is Here 💜 Solving Pancreatic Cancer’s First-Line Dilemma.

The FDA approval of RASONQUE™ (daraxonrasib) is an important step forward for people facing metastatic pancreatic cancer.

But for patients and families, it raises an even more important question:

How do we know which treatment is most likely to work for me—and when?

At Oncology CoPilot, we’re working toward a future where RNA sequencing, AI-guided treatment intelligence, functional testing, and real-world patient outcomes can help physicians better understand who may benefit from RASONQUE, chemotherapy, a combination, or another option.

The goal isn’t simply more treatments. It’s helping each patient and their care team make a more informed treatment decision, earlier.

Read our latest Substack: RASONQUE Is Here—Solving Pancreatic Cancer’s First-Line Dilemma

The FDA’s landmark approval of daraxonrasib opens a new door in 1st-line care. Here is how precision RNA routing can eliminate non-beneficial chemotherapy for up to 80% of patients.

08/22/2026

Cancer treatment is becoming more personalized but one important question remains:

How do we know which treatment is most likely to work for an individual patient?

ASCO is signaling support for advancing Functional Precision Medicine, creating an opportunity to bring AI-driven treatment intelligence and functional testing together.

The idea is simple:
1. Understand the tumor
2. Use AI to identify which therapies have the strongest rationale to test
3. Test selected therapies against the patient’s tumor sample or CTCs
4. Bring the evidence together to support better-informed treatment decisions

At Oncology CoPilot, we believe functional testing becomes far more powerful when it starts with an intelligence layer that helps determine what to test—and why.

AI helps identify what to test. Functional testing adds biological validation.
Because patients aren't looking for more treatment options.
They're looking for the right one for them.

Read the full article: ASCO Signals Support for Functional Precision Medicine

But Before We Test a Drug, How Do We Decide What to Test?

08/22/2026

Cancer treatment is becoming more personalized but one important question remains:

How do we know which treatment is most likely to work for an individual patient?

ASCO is signaling support for advancing Functional Precision Medicine, creating an opportunity to bring AI-driven treatment intelligence and functional testing together.

The idea is simple:

1. Understand the tumor
2. Use AI to identify which therapies have the strongest rationale to test
3. Test selected therapies against the patient’s tumor sample or CTCs
4. Bring the evidence together to support better-informed treatment decisions

At Oncology CoPilot, we believe functional testing becomes far more powerful when it starts with an intelligence layer that helps determine what to test—and why.

AI helps identify what to test. Functional testing adds biological validation.

Because patients aren't looking for more treatment options.

They're looking for the right one for them.

Read the full article: ASCO Signals Support for Functional Precision Medicine

07/15/2026

Why does cancer keep coming back?

Think about weeds.

You can spray what's visible, but if you don't understand what's happening beneath the surface, they'll often grow back—sometimes stronger than before.

Cancer behaves much the same way.

The future of precision oncology isn't just about new drugs. It's about understanding tumor biology, anticipating resistance, and adapting treatment over time.

That's the idea behind our latest article.

Read more:
https://open.substack.com/pub/oncologycopilot/p/why-treating-cancer-is-like-fighting

07/03/2026

Why do so many pancreatic cancer patients spend precious time on highly toxic chemo therapies that may never work?

Because Standard of Care Treats Population Averages, Not Individual Patients.

What if we could identify which pancreatic cancer patients are unlikely to benefit from standard chemotherapy before treatment begins and help guide them to better options sooner?

Explore these options from a patient perpective in our latest article

Why pancreatic cancer patients need faster, more personalized treatment decisions.

07/02/2026

https://www.linkedin.com/posts/edwinalphonso_httpslnkding4j6gj4q-share-7478310446886739968-Fo_w/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAxGedwB_NjFYwaKN-OBFP7BJYrvG5UBmAw

https://lnkd.in/g4J6GJ4q

06/30/2026

Welcome to Cancer Patient Lab

Cancer Patient Lab was created for moments like this.

Founded by Brad Power, it is a learning community, built by patients, for patients and caregivers, focused on helping people navigate complex testing and treatment decisions when the stakes are highest.

Because living with cancer isn’t just clinical.

It’s deeply personal.

There are moments of uncertainty.
Moments of isolation.
Moments where the next step isn’t clear.

And in those moments, what people need most isn’t more information.

They need clarity.
They need guidance.
They need support from people who understand the journey.

Through education, shared experience, and access to the right information, Cancer Patient Lab helps patients feel more empowered and better equipped to take an active role in their care.

“I was approaching the end of standard of care, running out of options fast. The Cancer Patient Lab community empowered me with knowledge and data so I could work with my oncologist to find a new path through my cancer.”
— Robert Ellis, Prostate Cancer Survivor

Introducing Cancer Patient Lab